←Back to Expert Scholars
Translational Medicine / 转化医学Leiomyosarcoma, Liposarcoma
Mark Dickson
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Sarcoma Medical Oncologist
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Mark Dickson leads sarcoma medical oncology trials at Memorial Sloan Kettering including CDK4 inhibitor studies in dedifferentiated liposarcoma. His work spans leiomyosarcoma and liposarcoma clinical trial design. He has defined activity of targeted agents in these subtypes.
Share:
🧪Research Fields 研究领域
leiomyosarcoma
liposarcoma
CDK4 inhibitors
sarcoma clinical trials
MDM2
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Mark Dickson 的研究动态
Follow Mark Dickson's research updates
留下邮箱，当我们发布与 Mark Dickson（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment